GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes

The Journal of Clinical Investigation
Vissia VigliettaD A Hafler

Abstract

Insulin-dependent type 1 diabetes is an autoimmune disease mediated by T lymphocytes recognizing pancreatic islet cell antigens. Glutamic acid decarboxylase 65 (GAD65) appears to be an important autoantigen in the disease. However, T cells from both patients with type 1 diabetes and healthy subjects vigorously proliferate in response to GAD65 stimulation ex vivo, leading us to postulate that the critical event in the onset of human diabetes is the activation of autoreactive T cells. Thus, we investigated whether GAD65-reactive T cells in patients with diabetes functioned as previously activated memory T cells, no longer requiring a second, costimulatory signal for clonal expansion. We found that in patients with new-onset type 1 diabetes, GAD65-reactive T cells were strikingly less dependent on CD28 and B7-1 costimulation to enter into cell cycle and proliferate than were equivalent cells derived from healthy controls. We hypothesize that these autoreactive T cells have been activated in vivo and have differentiated into memory cells, suggesting a pathogenic role in type 1 diabetes. In addition, we observed different effects with selective blockade of either B7-1 or B7-2 molecules; B7-1 appears to deliver a negative signal by e...Continue Reading

References

Nov 1, 1992·European Journal of Clinical Investigation·B O Roep, R R De Vries
Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Jun 15, 1990·Science·R H Schwartz
Jan 1, 1989·Annual Review of Immunology·I MüllerJ Louis
Mar 17, 1988·The New England Journal of Medicine·P F BougneresJ L Chaussain
Jul 16, 1987·Nature·J F BrunetP Golstein
May 22, 1986·The New England Journal of Medicine·G S Eisenbarth
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D J LenschowJ A Bluestone
Aug 1, 1994·The Journal of Experimental Medicine·K S HathcockR J Hodes
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C D GimmiL M Nadler
Nov 4, 1993·Nature·M AzumaC Somoza
May 26, 1995·Science·J D KatzD Mathis
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Jan 1, 1993·Annual Review of Immunology·P S Linsley, J A Ledbetter
May 3, 1996·Cell·R Tisch, H McDevitt
Jun 1, 1996·The Journal of Experimental Medicine·M F Krummel, J P Allison
Feb 12, 1998·The Journal of Experimental Medicine·J TianD L Kaufman
Feb 24, 2001·Genes and Immunity·O P KristiansenF Pociot

❮ Previous
Next ❯

Citations

Jan 24, 2007·Journal of Clinical Immunology·Deepak Yadav, Nora Sarvetnick
Mar 28, 2009·Current Diabetes Reports·Paolo MontiEzio Bonifacio
Aug 15, 2013·Current Diabetes Reports·J R F Abreu, B O Roep
Aug 22, 2007·Cell Biochemistry and Biophysics·Todd Brusko, Mark Atkinson
Jun 11, 2008·Immunologic Research·Bo Wang, Roland Tisch
Dec 5, 2008·Immunologic Research·Bo Wang, Roland Tisch
Dec 2, 2009·Nature Reviews. Drug Discovery·Heike WulffLuis A Pardo
Nov 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Christine BeetonK George Chandy
Nov 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lisa M MaierDavid A Hafler
Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Li ZhangGeorge S Eisenbarth
Apr 7, 2004·The Journal of Experimental Medicine·Vissia VigliettaDavid A Hafler
Jul 29, 2004·The Journal of Experimental Medicine·Clare Baecher-Allan, David A Hafler
Nov 11, 2005·American Journal of Therapeutics·Roberto Mallone, Gerald T Nepom
Jun 18, 2010·Transplantation·Adam D GriesemerMark A Hardy
Jan 6, 2009·Molecular Pharmacology·M W PenningtonK G Chandy
Dec 24, 2009·Journal of Biomedicine & Biotechnology·Laura GiulianiAlessandra Fierabracci
Apr 3, 2002·The Journal of Clinical Investigation·Ake Lernmark
Sep 4, 2003·The Journal of Clinical Investigation·Andrew P FontenotBrian L Kotzin
Jul 12, 2005·The Journal of Clinical Investigation·Francisco J QuintanaYechiel Shai
Aug 1, 2006·The Journal of Clinical Investigation·Stig TollefsenLudvig M Sollid
Oct 7, 2005·International Journal of Hematology·Shinji NakaoChiharu Sugimori
Sep 21, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Rosane Vianna-Jorge, Guilherme Suarez-Kurtz
Jul 6, 2014·Current Diabetes Reports·Paolo Monti, Ezio Bonifacio
Jun 11, 2011·Current Diabetes Reports·George W BurkeAlberto Pugliese
Aug 27, 2011·Toxicon : Official Journal of the International Society on Toxinology·Victor ChiK George Chandy
Feb 3, 2007·The Journal of Investigative Dermatology·Philippe AzamHeike Wulff
Mar 18, 2016·Current Diabetes Reports·Debora Vignali, Paolo Monti
May 5, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Patrick A OttPaul V Lehmann
May 6, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Elsa LaughlinGerald Nepom
Sep 6, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Daisuke ChujoHideki Ueno
Jan 10, 2018·Frontiers in Immunology·Matthew ClarkRoland M Tisch
Sep 14, 2018·Diabetologia·Chantal MathieuTimothy Tree
Aug 2, 2017·The Journal of Clinical Investigation·Alberto Pugliese
Aug 14, 2019·Frontiers in Neurology·Tetyana Blinder, Jan Lewerenz
Feb 20, 2021·Frontiers in Immunology·Matthew ClarkRoland M Tisch

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
ELISA

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.